1981
DOI: 10.1038/289300a0
|View full text |Cite
|
Sign up to set email alerts
|

Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines

Abstract: Cyclosporin A (CSA) is a fungal metabolite which exerts profound effects on the immune system and has potential as a selective immuno-suppressive agent. Clinical trials with human renal allograft recipients have confirmed this potential but there have been disturbing reports of lymphoma in a significant number of patients. Despite extensive animal studies, the specificity of this drug for human lymphocyte subpopulations is largely unknown. We demonstrate here that in vitro CSA has no apparent effect on Epstein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
79
0

Year Published

1985
1985
2009
2009

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 219 publications
(81 citation statements)
references
References 10 publications
2
79
0
Order By: Relevance
“…Evidence of monoclonality was observed in seven of these 17 patients. Five of the 17 patients, including three with monoclonal disease, received additional chemotherapy or radiotherapy, or both.…”
Section: Clinical Course and Therapymentioning
confidence: 93%
“…Evidence of monoclonality was observed in seven of these 17 patients. Five of the 17 patients, including three with monoclonal disease, received additional chemotherapy or radiotherapy, or both.…”
Section: Clinical Course and Therapymentioning
confidence: 93%
“…Briefly, MNC were isolated from peripheral blood as described above, and T cells were separated from B cells and monocytes by rosetting with AET erythrocytes. The rosette-negative fraction was then infected with EBV using a modification of the technique previously described (25). Supernatants from the B95-8 marmoset cell line were filtered through a 0.45-#m filter 6 (Nalge Co., Rochester, NY), diluted fourfold, and incubated with 5 x 10 cells in a sterile 12-× 74-mm tube (Falcon Labware, Oxnard, CA) for 1 h at 30°C.…”
Section: Methodsmentioning
confidence: 99%
“…SP-LCL were established by spontaneous outgrowth of PBL from EBV-seropositive donors in the presence of cyclosporin A. 11 For the establishment of these cell lines, the addition of exogenous EBV is not necessary. Briefly, 3 ϫ 10 7 peripheral blood mononuclear cells were purified by Ficoll gradient centrifugation (Pharmacia, Freiburg, Germany) and plated into 96-well plates at a density of 1 ϫ 10 6 cells/mL in RPMI 1640 (PAA Laboratories, Coelbe, Germany) supplemented with 10% fetal calf sera (FCS).…”
Section: Establishment Of Sp-lclmentioning
confidence: 99%
“…9,10 Most importantly, LCL can be easily obtained by culturing peripheral blood lymphocytes (PBL) from EBV-positive humans in vitro, because EBV-transformed B lymphocytes show a spontaneous outgrowth (SP-LCL) and can serve as a practically unlimited source of APC. 11 It was the aim of this study to determine whether and to what extent SP-LCL transfected with a tumor Ag can serve as an alternative autologous cellular vaccine for the induction of antitumoral T-cell immunity in cancer patients. To this end, SP-LCL from healthy donors and cancer patients were transfected with an episomal EBV-based expression plasmid encoding a tumor Ag.…”
mentioning
confidence: 99%